Theravance Biopharma (TBPH) Other Gross PP&E Adjustments: 2013-2025
Historic Other Gross PP&E Adjustments for Theravance Biopharma (TBPH) over the last 7 years, with Sep 2025 value amounting to -$25.4 million.
- Theravance Biopharma's Other Gross PP&E Adjustments rose 13.24% to -$25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.9 million, marking a year-over-year increase of 26.21%. This contributed to the annual value of $1.5 million for FY2024, which is 116.16% up from last year.
- Latest data reveals that Theravance Biopharma reported Other Gross PP&E Adjustments of -$25.4 million as of Q3 2025, which was up 3.94% from -$26.5 million recorded in Q2 2025.
- Over the past 5 years, Theravance Biopharma's Other Gross PP&E Adjustments peaked at $12.5 million during Q4 2021, and registered a low of -$42.5 million during Q1 2021.
- For the 3-year period, Theravance Biopharma's Other Gross PP&E Adjustments averaged around -$27.2 million, with its median value being -$29.3 million (2024).
- Per our database at Business Quant, Theravance Biopharma's Other Gross PP&E Adjustments spiked by 195.78% in 2021 and then tumbled by 3,259.58% in 2023.
- Over the past 5 years, Theravance Biopharma's Other Gross PP&E Adjustments (Quarterly) stood at $12.5 million in 2021, then plummeted by 97.70% to $287,000 in 2022, then crashed by 3,259.58% to -$9.1 million in 2023, then spiked by 116.16% to $1.5 million in 2024, then increased by 13.24% to -$25.4 million in 2025.
- Its Other Gross PP&E Adjustments was -$25.4 million in Q3 2025, compared to -$26.5 million in Q2 2025 and -$27.4 million in Q1 2025.